Predicting intrinsic clearance using deep learning-based drug-metabolic enzyme interaction features on an
Hyunjung Lee1, Hyeonseok Kang2, Jung-Woo Chae1
1Department of Bio-AI Convergence, Chungnam National University, Daejeon 34134, Republic of Korea; College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea.
Background And Objective:
Intrinsic clearance is a key pharmacokinetic parameter in drug development because it influences systemic exposure and dose selection. Conventional in vitro-in vivo extrapolation (IVIVE) approaches are useful but often require additional experimental resources and may be difficult to apply in the earliest stages of compound screening. This study aimed to develop a biologically informed computational framework for intrinsic clearance prediction by integrating drug-target interaction (DTI)-derived features from 23 hepatic metabolic proteins with physicochemical properties, using an IVIVE-based endpoint harmonization approach to unify heterogeneous endpoint labels.
Methods:
A multi-source human clearance dataset was assembled and harmonized into a common intrinsic clearance endpoint. A pretrained DTI model based on ChemBERTa and ProtBERT was used to generate precomputed interaction features for CYP, UGT, and SULT family proteins. These features were combined with compound structure and physicochemical descriptors in downstream clearance prediction models using either a multilayer perceptron (MLP) or a transformer encoder. Internal evaluation included repeated random 5-fold cross-validation and scaffold-split analysis, and an independent external evaluation set of 185 compounds was additionally examined.
Results:
Feature settings incorporating DTI-derived information showed improved regression performance compared with the descriptor-only baseline across most evaluated metrics. Under the augmented setting, the MLP model with DTI + LogP/Fup showed the highest overall regression performance among the evaluated models (r2m = 0.2505 ± 0.0792, r2 = 0.2364 ± 0.0879), while the highest CI was observed in the transformer encoder model with DTI + LogP/Fup (0.6915 ± 0.0144). On the external evaluation set, the MLP model showed an AFE of 1.116, with 52.970% and 70.792% of predictions falling within 2-fold and 3-fold error, respectively. Comparisons with published IVIVE-related studies should be interpreted as contextual rather than direct head-to-head validation.
Conclusions:
The proposed framework supports intrinsic clearance estimation by combining biologically informed DTI-derived features with physicochemical information in an interpretable prediction setting. Although the predictive performance remains modest, the results suggest potential utility as a supportive early-stage prioritization tool when standardized experimental clearance data are limited. Further work is needed to expand the dataset, strengthen external validation with independent cohorts, and incorporate additional elimination pathways such as renal clearance and transporter-mediated disposition.
Related Concept Videos
Drug Product Performance: In Vitro–In Vivo Correlation
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Determination of Renal Drug Clearance: Graphical and Midpoint Methods
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
